Taizhou Kangping Medical Science And Technology Co., Ltd.
FDA inspection history in Taizhou City, China, 2019 to 2025
- 1
- Warning letter
- 1
- Form 483
Every document, by year
- Warning letter
- Form 483
2019: one Form 483; 2025: one warning letter.
The story so far
Built from the dates and citations on the documents themselves.
- 2019One Form 483, at Taizhou City, China.
- 2025One warning letter.
Cited most
Across all Taizhou Kangping Medical Science And Technology Co. observations on file
- 21 CFR 211.130Packaging and labeling operations1
- 21 CFR 211.186Master production and control records1
- 21 CFR 211.192Production record review1
The complete Taizhou Kangping Medical Science And Technology Co. file.
All 2 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.
The price of the documents, added to your cart together
Sites
Taizhou City, China
One Form 483 · 2019 · 3 observations
Latest: Form 483, Mar 7, 2019 →
Also: one document not tied to a site.
Documents
2 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2025-10-09 | Warning letter Warning letter | — | — | $99 |
| 2019-03-07 | 483 Form 483 | Taizhou City, China | 3 | $99 |
FEI number 3013321339 · most recent document Oct 9, 2025
About Taizhou Kangping Medical Science And Technology Co., Ltd.
How many FDA Form 483s has Taizhou Kangping Medical Science And Technology Co., Ltd. received?
FDA Intel has 1 Form 483 on file for Taizhou Kangping Medical Science And Technology Co., Ltd.; the most recent is dated Mar 7, 2019.
When was Taizhou Kangping Medical Science And Technology Co., Ltd. last inspected by FDA?
The most recent FDA inspection document on file for Taizhou Kangping Medical Science And Technology Co., Ltd. is a Form 483 dated Mar 7, 2019, for the site in Taizhou City, China.
What did FDA cite at Taizhou Kangping Medical Science And Technology Co., Ltd.?
The regulations cited most in the observations on file for Taizhou Kangping Medical Science And Technology Co., Ltd. are 21 CFR 211.130 (Packaging and labeling operations), 1 time; 21 CFR 211.186 (Master production and control records), 1 time; 21 CFR 211.192 (Production record review), 1 time.
Has Taizhou Kangping Medical Science And Technology Co., Ltd. received an FDA warning letter?
Yes. FDA Intel has 1 FDA warning letter on file for Taizhou Kangping Medical Science And Technology Co., Ltd.; the most recent is dated Oct 9, 2025.